PI 3-Kinase and the Histone Methyl-Transferase KMT2D Collaborate to Induce Arp2/3-Dependent Migration of Mammary...

Area of Science:

• Cell Biology
• Molecular Oncology
• Cancer Research

Background:

• Breast cancer arises from accumulated genetic mutations in mammary cells.
• The collaborative mechanisms of these mutations in cell transformation are not fully understood.
• Investigating specific mutation combinations can elucidate early cancer development.

Purpose of the Study:

• To reconstitute and study the collaborative effects of specific driver mutations in breast cancer development.
• To investigate the roles of PI 3-kinase activation and KMT2D inactivation in mammary epithelial cell transformation.
• To identify the molecular mechanisms underlying synergistic effects on cell migration.

Main Methods:

• Utilized the MCF10A human mammary epithelial cell line.
• Introduced activated PI 3-kinase (H1047R mutation) and inactivated KMT2D.
• Assessed cell-cycle progression, collective monolayer migration, and single-cell migration.
• Analyzed gene expression changes, including ARPC5L, and utilized gene depletion (ARPC5L) to confirm mechanisms.

Main Results:

• PI 3-kinase activation enhanced cell-cycle progression and migration.
• KMT2D inactivation primarily affected single-cell migration synergistically with PI 3-kinase activation.
• The combined mutations upregulated ARPC5L, a subunit of the Arp2/3 complex.
• ARPC5L depletion reversed the enhanced migration persistence in double-mutant cells.

Conclusions:

• The synergistic interaction between PI 3-kinase activation and KMT2D inactivation drives specific cell functions, notably enhanced single-cell migration.
• Upregulation of ARPC5L and the Arp2/3 complex is a key mechanism mediating this enhanced migration.
• This reconstitution model provides insights into the collaborative roles of driver mutations in early breast cancer progression.